Indicators for monitoring the technique of transcutaneous immunization

• US 20040047872A1
• Filed: 09/10/2003
• Published: 03/11/2004
• Est. Priority Date: 11/14/1996
• Status: Abandoned Application

• Current Assignee: US Department of The Army (Government of the United States of America)
• Original Assignee: US Department of The Army (Government of the United States of America)
• Inventors: Glenn, Gregory M., Alving, Carl R.
• Application Number:
  US10/658,418
• Publication Number:
  US 20040047872A1
• Time in Patent Office: Days
• US Class Current: 424/184.1
• CPC Class Codes: A61K 2039/54 characterised by the route of administration
• CPC Class Codes: A61K 2039/55511 Organic adjuvants
• CPC Class Codes: A61K 2039/55527 Interleukins
• CPC Class Codes: A61K 2039/55544 Bacterial toxins
• CPC Class Codes: A61K 2039/55555 Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
• CPC Class Codes: A61K 2039/55566 Emulsions, e.g. Freund's adjuvant, MF59
• CPC Class Codes: A61K 39/00 Medicinal preparations containing antigens or antibodies materials for immunoassay G01N33/53
• CPC Class Codes: A61K 39/39 characterised by the immunostimulating additives, e.g. chemical adjuvants
• CPC Class Codes: A61K 9/0017 Non-human animal skin, e.g. pour-on, spot-on
• CPC Class Codes: A61K 9/06 Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels composition of ointments, creams or gels A61K47/00
• CPC Class Codes: A61K 9/08 Solutions composition of solutions A61K47/00
• CPC Class Codes: A61K 9/107 Emulsions ; Emulsion preconcentrates; Micelles composition of emulsions A61K47/00
• CPC Class Codes: A61K 9/127 Liposomes
• CPC Class Codes: A61K 9/7023 Transdermal patches and similar drug-containing composite devices, e.g. cataplasms galenical aspects of iontophoretic devices A61K9/0009; microneedle arrays A61K9/0021; buccal patches A61K9/006

Abstract

Transcutaneous immunization system delivers antigen to immune cells through topical application, and induces an antigen-specific immune response in an animal or human. The improvement involve a system for marking the successful delivery of the immunization using indicators or using marking systems to allow better application of the patch to a prepared skin surface.

Claims

1. A transcutaneous immunization system, for immunizing a subject comprising:

a transcutaneous immunization formulation;

said immunization formulation comprising at least one antigen, and

a marking formulation;

said marking formulation comprising at least one chemical indicator, the presence of said indicator serving to provide a readily discernable indication of the use of said immunization formulation,

wherein said transcutaneous immunization system provides an antigen specific immune response in the subject following the application of said system to intact skin of said subject.

2. The immunization system of claim 1, wherein said immunization formulation further comprises an adjuvant.

3. The immunization system of claim 1, wherein said chemical indicator also acts as an adjuvant.

4. The immunization system of claim 1, wherein said indicator further provides an indication of the length of time to which said subject has been exposed to said immunization formulation.

5. The immunization system of claim 4, wherein said length of time is determinable by said indicator taking on a color, changing color, or loosing the appearance of a color.

6. The immunization system of claim 4, wherein said antigen is two or more specific antigens and said at least one indicator provides a specific, distinctive, discernable indication for each of said two or more specific antigens.

7. The immunization system of claim 1, wherein said indication is discernable by visual or olfactory senses.

8. The immunization system of claim 1, wherein said indicator is formulated to deactivate said antigen after a specific time of exposure of said antigen to said subject.

9. The immunization system of claim 1, wherein said indicator provides an indication of the degree of hydration of the skin surface of the subject.

10. The immunization system of claim 2, wherein said indicator is associated with said antigen or adjuvant by covalent bonding, hydrophobic forces, Van der Waals or aggregated, or admixed.

11. The immunization system of claim 10, wherein said indicator is a florescent tag.

12. The immunization system of claim 1, wherein said indicator provides a discemable indication of specific antigen present in said immunization formulation, the time span of the immunization application, or the effectiveness of said immunization application.

13. The immunization syst em of claim 1, wherein said indicator is selected from the group consisting of dye, ink, vital stain, Evans blue, paint, natural colorings, oxides, chlorophyll, charcoals, chalks, powders, pH indicators, peroxidase triggered or enzyme triggered compound, florescent compound, radioactive tag, attached to beads, and gold particles.

14. The immunization system of claim 1, further comprising an applicator, said applicator being selected from the group consisting of a patch, cream, ointment, gel, and any combination thereof.

15. The immunization system of claim 10, wherein said applicator is a patch.

16. The immunization system of claim 15, wherein said patch comprises a controlled release reservoir, a matrix, or a rate controlling membrane for stepped release of said immunization formulation.

17. The immunization system of claim 1, wherein said subject is an animal.

18. The immunization system of claim 17, wherein said system is deliverable by means of an air gun.

19. The immunization system of claim 17, wherein said system is formulated to induce said animal to lick or smell said formulation from the application site on the skin.

20. The immunization system of claim 17, wherein said system is formulated to inhibit the animal from licking or smelling said formulation from the application site on the skin.

21. A method for eliciting an immune response from a subject by the application of an immunization system, said method comprising:

applying an immunization formulation to at least one application site on the intact skin of a subject, said immunization formulation comprising at least one antigen; and

applying a marking formulation to said at least one application site,

wherein said method provides an antigen specific immune response in the subject following the application of said system to intact skin of said subject.

22. The method of claim 21, further comprising pre-treating said intact skin by tape stripping, washing, or swabbing with alcohol or acetone.

23. The method of claim 21, further comprising applying said method to more than one application site on said subject.

24. The method of claim 21, further comprising applying said method to a site overlying more than one draining lymph node.

25. The method of claim 21, wherein said antigen is selected from the group consisting of pathogen derived antigen, tumor antigen and autoantigen.